학술논문
Survival, neurocognitive function, and health-related quality of life outcomes after rituximab—methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final results of the HOVON 105/ALLG NHL 24 study.
Document Type
Article
Author
Bromberg, Jacoline E C; Issa, Samar; van der Holt, Bronno; van der Meulen, Matthijs; Dirven, Linda; Minnema, Monique C; Seute, Tatjana; Durian, Marc; Cull, Gavin; Poel, Marjolein W M van der; Stevens, Wendy B C; Zijlstra, Josee M; Brandsma, Dieta; Nijland, Marcel; Mason, Kylie D; Beeker, Aart; Abrahamse-Testroote, Martine C J; Bent, Martin J van den; Jong, Daphne de; Doorduijn, Jeanette K
Source
Neuro-Oncology; Apr2024, Vol. 26 Issue 4, p724-734, 11p
Subject
Language
ISSN
15228517